img

Global Opioids Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Opioids Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The global Opioids market size was US$ 10050 million in 2022 and is forecast to a readjusted size of US$ 14730 million by 2034 with a CAGR of 5.5% during the forecast period 2024-2034.
Global Opioids Drug main players are Purdue Pharma, Teva, Pfizer, Hikma, etc. Global top four manufacturers hold a share over 40%. North America is the largest market, with a share nearly 70%.
In terms of sales (consumption) side, this report focuses on the sales of Opioids by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Opioids market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Opioids market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
By Type
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
By Application
Pain Relief
Anesthesia
Cough Suppression
Diarrhea Suppression
Deaddiction
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Opioids in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Opioids manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Opioids sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Opioids Definition
1.2 Market by Type
1.2.1 Global Opioids Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Other
1.3 Market Segment by Application
1.3.1 Global Opioids Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Cough Suppression
1.3.5 Diarrhea Suppression
1.3.6 Deaddiction
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Opioids Sales
2.1 Global Opioids Revenue Estimates and Forecasts 2018-2034
2.2 Global Opioids Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Opioids Revenue by Region
2.3.1 Global Opioids Revenue by Region (2018-2024)
2.3.2 Global Opioids Revenue by Region (2024-2034)
2.4 Global Opioids Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Opioids Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Opioids Sales Quantity by Region
2.6.1 Global Opioids Sales Quantity by Region (2018-2024)
2.6.2 Global Opioids Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Opioids Sales Quantity by Manufacturers
3.1.1 Global Opioids Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Opioids Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Opioids Sales in 2022
3.2 Global Opioids Revenue by Manufacturers
3.2.1 Global Opioids Revenue by Manufacturers (2018-2024)
3.2.2 Global Opioids Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Opioids Revenue in 2022
3.3 Global Opioids Sales Price by Manufacturers
3.4 Global Key Players of Opioids, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Opioids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Opioids, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Opioids, Product Offered and Application
3.8 Global Key Manufacturers of Opioids, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Opioids Sales Quantity by Type
4.1.1 Global Opioids Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Opioids Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Opioids Sales Quantity Market Share by Type (2018-2034)
4.2 Global Opioids Revenue by Type
4.2.1 Global Opioids Historical Revenue by Type (2018-2024)
4.2.2 Global Opioids Forecasted Revenue by Type (2024-2034)
4.2.3 Global Opioids Revenue Market Share by Type (2018-2034)
4.3 Global Opioids Price by Type
4.3.1 Global Opioids Price by Type (2018-2024)
4.3.2 Global Opioids Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Opioids Sales Quantity by Application
5.1.1 Global Opioids Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Opioids Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Opioids Sales Quantity Market Share by Application (2018-2034)
5.2 Global Opioids Revenue by Application
5.2.1 Global Opioids Historical Revenue by Application (2018-2024)
5.2.2 Global Opioids Forecasted Revenue by Application (2024-2034)
5.2.3 Global Opioids Revenue Market Share by Application (2018-2034)
5.3 Global Opioids Price by Application
5.3.1 Global Opioids Price by Application (2018-2024)
5.3.2 Global Opioids Price Forecast by Application (2024-2034)
6 North America
6.1 North America Opioids Sales by Company
6.1.1 North America Opioids Revenue by Company (2018-2024)
6.1.2 North America Opioids Sales Quantity by Company (2018-2024)
6.2 North America Opioids Market Size by Type
6.2.1 North America Opioids Sales Quantity by Type (2018-2034)
6.2.2 North America Opioids Revenue by Type (2018-2034)
6.3 North America Opioids Market Size by Application
6.3.1 North America Opioids Sales Quantity by Application (2018-2034)
6.3.2 North America Opioids Revenue by Application (2018-2034)
6.4 North America Opioids Market Size by Country
6.4.1 North America Opioids Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Opioids Revenue by Country (2018-2034)
6.4.3 North America Opioids Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Opioids Sales by Company
7.1.1 Europe Opioids Sales Quantity by Company (2018-2024)
7.1.2 Europe Opioids Revenue by Company (2018-2024)
7.2 Europe Opioids Market Size by Type
7.2.1 Europe Opioids Sales Quantity by Type (2018-2034)
7.2.2 Europe Opioids Revenue by Type (2018-2034)
7.3 Europe Opioids Market Size by Application
7.3.1 Europe Opioids Sales Quantity by Application (2018-2034)
7.3.2 Europe Opioids Revenue by Application (2018-2034)
7.4 Europe Opioids Market Size by Country
7.4.1 Europe Opioids Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Opioids Revenue by Country (2018-2034)
7.4.3 Europe Opioids Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Opioids Sales by Company
8.1.1 China Opioids Sales Quantity by Company (2018-2024)
8.1.2 China Opioids Revenue by Company (2018-2024)
8.2 China Opioids Market Size by Type
8.2.1 China Opioids Sales Quantity by Type (2018-2034)
8.2.2 China Opioids Revenue by Type (2018-2034)
8.3 China Opioids Market Size by Application
8.3.1 China Opioids Sales Quantity by Application (2018-2034)
8.3.2 China Opioids Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Opioids Sales by Company
9.1.1 APAC Opioids Sales Quantity by Company (2018-2024)
9.1.2 APAC Opioids Revenue by Company (2018-2024)
9.2 APAC Opioids Market Size by Type
9.2.1 APAC Opioids Sales Quantity by Type (2018-2034)
9.2.2 APAC Opioids Revenue by Type (2018-2034)
9.3 APAC Opioids Market Size by Application
9.3.1 APAC Opioids Sales Quantity by Application (2018-2034)
9.3.2 APAC Opioids Revenue by Application (2018-2034)
9.4 APAC Opioids Market Size by Region
9.4.1 APAC Opioids Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Opioids Revenue by Region (2018-2034)
9.4.3 APAC Opioids Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Opioids Sales by Company
10.1.1 Middle East, Africa and Latin America Opioids Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Opioids Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Opioids Market Size by Type
10.2.1 Middle East, Africa and Latin America Opioids Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Opioids Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Opioids Market Size by Application
10.3.1 Middle East, Africa and Latin America Opioids Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Opioids Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Opioids Market Size by Country
10.4.1 Middle East, Africa and Latin America Opioids Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Opioids Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Opioids Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Overview
11.1.3 Teva Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Teva Opioids Products and Services
11.1.5 Teva Opioids SWOT Analysis
11.1.6 Teva Recent Developments
11.2 Purdue Pharma
11.2.1 Purdue Pharma Company Information
11.2.2 Purdue Pharma Overview
11.2.3 Purdue Pharma Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Purdue Pharma Opioids Products and Services
11.2.5 Purdue Pharma Opioids SWOT Analysis
11.2.6 Purdue Pharma Recent Developments
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Information
11.3.2 Mallinckrodt Overview
11.3.3 Mallinckrodt Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Mallinckrodt Opioids Products and Services
11.3.5 Mallinckrodt Opioids SWOT Analysis
11.3.6 Mallinckrodt Recent Developments
11.4 Amneal Pharma
11.4.1 Amneal Pharma Company Information
11.4.2 Amneal Pharma Overview
11.4.3 Amneal Pharma Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Amneal Pharma Opioids Products and Services
11.4.5 Amneal Pharma Opioids SWOT Analysis
11.4.6 Amneal Pharma Recent Developments
11.5 Collegium
11.5.1 Collegium Company Information
11.5.2 Collegium Overview
11.5.3 Collegium Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Collegium Opioids Products and Services
11.5.5 Collegium Opioids SWOT Analysis
11.5.6 Collegium Recent Developments
11.6 J&J
11.6.1 J&J Company Information
11.6.2 J&J Overview
11.6.3 J&J Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 J&J Opioids Products and Services
11.6.5 J&J Opioids SWOT Analysis
11.6.6 J&J Recent Developments
11.7 Endo
11.7.1 Endo Company Information
11.7.2 Endo Overview
11.7.3 Endo Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Endo Opioids Products and Services
11.7.5 Endo Opioids SWOT Analysis
11.7.6 Endo Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Pfizer Opioids Products and Services
11.8.5 Pfizer Opioids SWOT Analysis
11.8.6 Pfizer Recent Developments
11.9 INSYS
11.9.1 INSYS Company Information
11.9.2 INSYS Overview
11.9.3 INSYS Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 INSYS Opioids Products and Services
11.9.5 INSYS Opioids SWOT Analysis
11.9.6 INSYS Recent Developments
11.10 Mylan
11.10.1 Mylan Company Information
11.10.2 Mylan Overview
11.10.3 Mylan Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Mylan Opioids Products and Services
11.10.5 Mylan Opioids SWOT Analysis
11.10.6 Mylan Recent Developments
11.11 Hikma
11.11.1 Hikma Company Information
11.11.2 Hikma Overview
11.11.3 Hikma Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Hikma Opioids Products and Services
11.11.5 Hikma Recent Developments
11.12 Egalet
11.12.1 Egalet Company Information
11.12.2 Egalet Overview
11.12.3 Egalet Opioids Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Egalet Opioids Products and Services
11.12.5 Egalet Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Opioids Value Chain Analysis
12.2 Opioids Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Opioids Production Mode & Process
12.4 Opioids Sales and Marketing
12.4.1 Opioids Sales Channels
12.4.2 Opioids Distributors
12.5 Opioids Customers
13 Market Dynamics
13.1 Opioids Industry Trends
13.2 Opioids Market Drivers
13.3 Opioids Market Challenges
13.4 Opioids Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Opioids Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Oxycodone
Table 3. Major Manufacturers of Hydromorphone
Table 4. Major Manufacturers of Codeine
Table 5. Major Manufacturers of Fentanyl
Table 6. Major Manufacturers of Other
Table 7. Global Opioids Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Opioids Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Opioids Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Opioids Revenue Market Share by Region (2018-2024)
Table 11. Global Opioids Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Opioids Revenue Market Share by Region (2024-2034)
Table 13. Global Opioids Sales Quantity by Region: 2018 VS 2022 VS 2034 (MT)
Table 14. Global Opioids Sales by Region (2018-2024) & (MT)
Table 15. Global Opioids Sales Market Share by Region (2018-2024)
Table 16. Global Opioids Sales by Region (2024-2034) & (MT)
Table 17. Global Opioids Sales Market Share by Region (2024-2034)
Table 18. Global Opioids Sales Quantity by Manufacturers (2018-2024) & (MT)
Table 19. Global Opioids Sales Quantity Share by Manufacturers (2018-2024)
Table 20. Global Opioids Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Opioids Revenue Share by Manufacturers (2018-2024)
Table 22. Global Opioids Price by Manufacturers 2018-2024 (USD/Kg)
Table 23. Global Key Players of Opioids, Industry Ranking, 2021 VS 2022
Table 24. Global Opioids Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Opioids by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids as of 2022)
Table 26. Global Key Manufacturers of Opioids, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Opioids, Product Offered and Application
Table 28. Global Key Manufacturers of Opioids, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Opioids Sales Quantity by Type (2018-2024) & (MT)
Table 31. Global Opioids Sales Quantity by Type (2024-2034) & (MT)
Table 32. Global Opioids Sales Quantity Share by Type (2018-2024)
Table 33. Global Opioids Sales Quantity Share by Type (2024-2034)
Table 34. Global Opioids Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Opioids Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Opioids Revenue Share by Type (2018-2024)
Table 37. Global Opioids Revenue Share by Type (2024-2034)
Table 38. Opioids Price by Type (2018-2024) & (USD/Kg)
Table 39. Global Opioids Price Forecast by Type (2024-2034) & (USD/Kg)
Table 40. Global Opioids Sales Quantity by Application (2018-2024) & (MT)
Table 41. Global Opioids Sales Quantity by Application (2024-2034) & (MT)
Table 42. Global Opioids Sales Quantity Share by Application (2018-2024)
Table 43. Global Opioids Sales Quantity Share by Application (2024-2034)
Table 44. Global Opioids Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Opioids Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Opioids Revenue Share by Application (2018-2024)
Table 47. Global Opioids Revenue Share by Application (2024-2034)
Table 48. Opioids Price by Application (2018-2024) & (USD/Kg)
Table 49. Global Opioids Price Forecast by Application (2024-2034) & (USD/Kg)
Table 50. North America Opioids Revenue by Company (2018-2024) & (US$ Million)
Table 51. North America Opioids Sales Quantity by Company (2018-2024) & (MT)
Table 52. North America Opioids Sales Quantity by Type (2018-2024) & (MT)
Table 53. North America Opioids Sales Quantity by Type (2024-2034) & (MT)
Table 54. North America Opioids Revenue by Type (2018-2024) & (US$ Million)
Table 55. North America Opioids Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Opioids Sales Quantity by Application (2018-2024) & (MT)
Table 57. North America Opioids Sales Quantity by Application (2024-2034) & (MT)
Table 58. North America Opioids Revenue by Application (2018-2024) & (US$ Million)
Table 59. North America Opioids Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Opioids Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 61. North America Opioids Revenue by Country (2018-2024) & (US$ Million)
Table 62. North America Opioids Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Opioids Sales Quantity by Country (2018-2024) & (MT)
Table 64. North America Opioids Sales Quantity by Country (2024-2034) & (MT)
Table 65. Europe Opioids Sales Quantity by Company (2018-2024) & (MT)
Table 66. Europe Opioids Revenue by Company (2018-2024) & (US$ Million)
Table 67. Europe Opioids Sales Quantity by Type (2018-2024) & (MT)
Table 68. Europe Opioids Sales Quantity by Type (2024-2034) & (MT)
Table 69. Europe Opioids Revenue by Type (2018-2024) & (US$ Million)
Table 70. Europe Opioids Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Opioids Sales Quantity by Application (2018-2024) & (MT)
Table 72. Europe Opioids Sales Quantity by Application (2024-2034) & (MT)
Table 73. Europe Opioids Revenue by Application (2018-2024) & (US$ Million)
Table 74. Europe Opioids Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Opioids Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 76. Europe Opioids Revenue by Country (2018-2024) & (US$ Million)
Table 77. Europe Opioids Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Opioids Sales Quantity by Country (2018-2024) & (MT)
Table 79. Europe Opioids Sales Quantity by Country (2024-2034) & (MT)
Table 80. China Opioids Sales Quantity by Company (2018-2024) & (MT)
Table 81. China Opioids Revenue by Company (2018-2024) & (US$ Million)
Table 82. China Opioids Sales Quantity by Type (2018-2024) & (MT)
Table 83. China Opioids Sales Quantity by Type (2024-2034) & (MT)
Table 84. China Opioids Revenue by Type (2018-2024) & (US$ Million)
Table 85. China Opioids Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Opioids Sales Quantity by Application (2018-2024) & (MT)
Table 87. China Opioids Sales Quantity by Application (2024-2034) & (MT)
Table 88. China Opioids Revenue by Application (2018-2024) & (US$ Million)
Table 89. China Opioids Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Opioids Sales Quantity by Company (2018-2024) & (MT)
Table 91. APAC Opioids Revenue by Company (2018-2024) & (US$ Million)
Table 92. APAC Opioids Sales Quantity by Type (2018-2024) & (MT)
Table 93. APAC Opioids Sales Quantity by Type (2024-2034) & (MT)
Table 94. APAC Opioids Revenue by Type (2018-2024) & (US$ Million)
Table 95. APAC Opioids Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Opioids Sales Quantity by Application (2018-2024) & (MT)
Table 97. APAC Opioids Sales Quantity by Application (2024-2034) & (MT)
Table 98. APAC Opioids Revenue by Application (2018-2024) & (US$ Million)
Table 99. APAC Opioids Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Opioids Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 101. APAC Opioids Revenue by Region (2018-2024) & (US$ Million)
Table 102. APAC Opioids Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Opioids Sales Quantity by Region (2018-2024) & (MT)
Table 104. APAC Opioids Sales Quantity by Region (2024-2034) & (MT)
Table 105. Middle East, Africa and Latin America Opioids Sales Quantity by Company (2018-2024) & (MT)
Table 106. Middle East, Africa and Latin America Opioids Revenue by Company (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Opioids Sales Quantity by Type (2018-2024) & (MT)
Table 108. Middle East, Africa and Latin America Opioids Sales Quantity by Type (2024-2034) & (MT)
Table 109. Middle East, Africa and Latin America Opioids Revenue by Type (2018-2024) & (US$ Million)
Table 110. Middle East, Africa and Latin America Opioids Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Opioids Sales Quantity by Application (2018-2024) & (MT)
Table 112. Middle East, Africa and Latin America Opioids Sales Quantity by Application (2024-2034) & (MT)
Table 113. Middle East, Africa and Latin America Opioids Revenue by Application (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Opioids Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Opioids Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Opioids Revenue by Country (2018-2024) & (US$ Million)
Table 117. Middle East, Africa and Latin America Opioids Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Opioids Sales Quantity by Country (2018-2024) & (MT)
Table 119. Middle East, Africa and Latin America Opioids Sales Quantity by Country (2024-2034) & (MT)
Table 120. Teva Company Information
Table 121. Teva Description and Overview
Table 122. Teva Opioids Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 123. Teva Opioids Product and Services
Table 124. Teva Opioids SWOT Analysis
Table 125. Teva Recent Developments
Table 126. Purdue Pharma Company Information
Table 127. Purdue Pharma Description and Overview
Table 128. Purdue Pharma Opioids Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 129. Purdue Pharma Opioids Product and Services
Table 130. Purdue Pharma Opioids SWOT Analysis
Table 131. Purdue Pharma Recent Developments
Table 132. Mallinckrodt Company Information
Table 133. Mallinckrodt Description and Overview
Table 134. Mallinckrodt Opioids Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 135. Mallinckrodt Opioids Product and Services
Table 136. Mallinckrodt Opioids SWOT Analysis
Table 137. Mallinckrodt Recent Developments
Table 138. Amneal Pharma Company Information
Table 139. Amneal Pharma Description and Overview
Table 140. Amneal Pharma Opioids Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 141. Amneal Pharma Opioids Product and Services
Table 142. Amneal Pharma Opioids SWOT Analysis
Table 143. Amneal Pharma Recent Developments
Table 144. Collegium Company Information
Table 145. Collegium Description and Overview
Table 146. Collegium Opioids Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 147. Collegium Opioids Product and Services
Table 148. Collegium Opioids SWOT Analysis
Table 149. Collegium Recent Developments
Table 150. J&J Company Information
Table 151. J&J Description and Overview
Table 152. J&J Opioids Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 153. J&J Opioids Product and Services
Table 154. J&J Opioids SWOT Analysis
Table 155. J&J Recent Developments
Table 156. Endo Company Information
Table 157. Endo Description and Overview
Table 158. Endo Opioids Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 159. Endo Opioids Product and Services
Table 160. Endo Opioids SWOT Analysis
Table 161. Endo Recent Developments
Table 162. Pfizer Company Information
Table 163. Pfizer Description and Overview
Table 164. Pfizer Opioids Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 165. Pfizer Opioids Product and Services
Table 166. Pfizer Opioids SWOT Analysis
Table 167. Pfizer Recent Developments
Table 168. INSYS Company Information
Table 169. INSYS Description and Overview
Table 170. INSYS Opioids Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 171. INSYS Opioids Product and Services
Table 172. INSYS Opioids SWOT Analysis
Table 173. INSYS Recent Developments
Table 174. Mylan Company Information
Table 175. Mylan Description and Overview
Table 176. Mylan Opioids Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 177. Mylan Opioids Product and Services
Table 178. Mylan Opioids SWOT Analysis
Table 179. Mylan Recent Developments
Table 180. Hikma Company Information
Table 181. Hikma Description and Overview
Table 182. Hikma Opioids Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 183. Hikma Opioids Product and Services
Table 184. Hikma Recent Developments
Table 185. Egalet Company Information
Table 186. Egalet Description and Overview
Table 187. Egalet Opioids Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/Kg) and Gross Margin (2018-2024)
Table 188. Egalet Opioids Product and Services
Table 189. Egalet Recent Developments
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Opioids Distributors List
Table 193. Opioids Customers List
Table 194. Opioids Market Trends
Table 195. Opioids Market Drivers
Table 196. Opioids Market Challenges
Table 197. Opioids Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Product Picture
Figure 2. Global Opioids Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Opioids Market Share by Type in 2022 & 2034
Figure 4. Oxycodone Product Picture
Figure 5. Hydromorphone Product Picture
Figure 6. Codeine Product Picture
Figure 7. Fentanyl Product Picture
Figure 8. Other Product Picture
Figure 9. Global Opioids Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 10. Global Opioids Market Share by Application in 2022 & 2034
Figure 11. Pain Relief
Figure 12. Anesthesia
Figure 13. Cough Suppression
Figure 14. Diarrhea Suppression
Figure 15. Deaddiction
Figure 16. Others
Figure 17. Opioids Report Years Considered
Figure 18. Global Opioids Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 19. Global Opioids Revenue 2018-2034 (US$ Million)
Figure 20. Global Opioids Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 21. Global Opioids Sales Quantity 2018-2034 (MT)
Figure 22. Global Opioids Sales Quantity Market Share by Region (2018-2024)
Figure 23. Global Opioids Sales Quantity Market Share by Region (2024-2034)
Figure 24. North America Opioids Sales Quantity YoY (2018-2034) & (MT)
Figure 25. North America Opioids Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Europe Opioids Sales Quantity YoY (2018-2034) & (MT)
Figure 27. Europe Opioids Revenue YoY (2018-2034) & (US$ Million)
Figure 28. China Opioids Sales Quantity YoY (2018-2034) & (MT)
Figure 29. China Opioids Revenue YoY (2018-2034) & (US$ Million)
Figure 30. APAC Opioids Sales Quantity YoY (2018-2034) & (MT)
Figure 31. APAC Opioids Revenue YoY (2018-2034) & (US$ Million)
Figure 32. Middle East, Africa and Latin America Opioids Sales Quantity YoY (2018-2034) & (MT)
Figure 33. Middle East, Africa and Latin America Opioids Revenue YoY (2018-2034) & (US$ Million)
Figure 34. The Top 10 and Top 5 Players Market Share by Opioids Sales Quantity in 2022
Figure 35. The Top 10 and Top 5 Players Market Share by Opioids Revenue in 2022
Figure 36. Opioids Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 37. Global Opioids Sales Quantity Market Share by Type (2018-2034)
Figure 38. Global Opioids Revenue Market Share by Type (2018-2034)
Figure 39. Global Opioids Sales Quantity Market Share by Application (2018-2034)
Figure 40. Global Opioids Revenue Market Share by Application (2018-2034)
Figure 41. North America Opioids Revenue Market Share by Company in 2022
Figure 42. North America Opioids Sales Quantity Market Share by Company in 2022
Figure 43. North America Opioids Sales Quantity Market Share by Type (2018-2034)
Figure 44. North America Opioids Revenue Market Share by Type (2018-2034)
Figure 45. North America Opioids Sales Quantity Market Share by Application (2018-2034)
Figure 46. North America Opioids Revenue Market Share by Application (2018-2034)
Figure 47. North America Opioids Revenue Share by Country (2018-2034)
Figure 48. North America Opioids Sales Quantity Share by Country (2018-2034)
Figure 49. U.S. Opioids Revenue (2018-2034) & (US$ Million)
Figure 50. Canada Opioids Revenue (2018-2034) & (US$ Million)
Figure 51. Europe Opioids Sales Quantity Market Share by Company in 2022
Figure 52. Europe Opioids Revenue Market Share by Company in 2022
Figure 53. Europe Opioids Sales Quantity Market Share by Type (2018-2034)
Figure 54. Europe Opioids Revenue Market Share by Type (2018-2034)
Figure 55. Europe Opioids Sales Quantity Market Share by Application (2018-2034)
Figure 56. Europe Opioids Revenue Market Share by Application (2018-2034)
Figure 57. Europe Opioids Revenue Share by Country (2018-2034)
Figure 58. Europe Opioids Sales Quantity Share by Country (2018-2034)
Figure 59. Germany Opioids Revenue (2018-2034) & (US$ Million)
Figure 60. France Opioids Revenue (2018-2034) & (US$ Million)
Figure 61. U.K. Opioids Revenue (2018-2034) & (US$ Million)
Figure 62. Italy Opioids Revenue (2018-2034) & (US$ Million)
Figure 63. Russia Opioids Revenue (2018-2034) & (US$ Million)
Figure 64. China Opioids Sales Quantity Market Share by Company in 2022
Figure 65. China Opioids Revenue Market Share by Company in 2022
Figure 66. China Opioids Sales Quantity Market Share by Type (2018-2034)
Figure 67. China Opioids Revenue Market Share by Type (2018-2034)
Figure 68. China Opioids Sales Quantity Market Share by Application (2018-2034)
Figure 69. China Opioids Revenue Market Share by Application (2018-2034)
Figure 70. APAC Opioids Sales Quantity Market Share by Company in 2022
Figure 71. APAC Opioids Revenue Market Share by Company in 2022
Figure 72. APAC Opioids Sales Quantity Market Share by Type (2018-2034)
Figure 73. APAC Opioids Revenue Market Share by Type (2018-2034)
Figure 74. APAC Opioids Sales Quantity Market Share by Application (2018-2034)
Figure 75. APAC Opioids Revenue Market Share by Application (2018-2034)
Figure 76. APAC Opioids Revenue Share by Region (2018-2034)
Figure 77. APAC Opioids Sales Quantity Share by Region (2018-2034)
Figure 78. Japan Opioids Revenue (2018-2034) & (US$ Million)
Figure 79. South Korea Opioids Revenue (2018-2034) & (US$ Million)
Figure 80. China Taiwan Opioids Revenue (2018-2034) & (US$ Million)
Figure 81. Southeast Asia Opioids Revenue (2018-2034) & (US$ Million)
Figure 82. India Opioids Revenue (2018-2034) & (US$ Million)
Figure 83. Middle East, Africa and Latin America Opioids Sales Quantity Market Share by Company in 2022
Figure 84. Middle East, Africa and Latin America Opioids Revenue Market Share by Company in 2022
Figure 85. Middle East, Africa and Latin America Opioids Sales Quantity Market Share by Type (2018-2034)
Figure 86. Middle East, Africa and Latin America Opioids Revenue Market Share by Type (2018-2034)
Figure 87. Middle East, Africa and Latin America Opioids Sales Quantity Market Share by Application (2018-2034)
Figure 88. Middle East, Africa and Latin America Opioids Revenue Market Share by Application (2018-2034)
Figure 89. Middle East, Africa and Latin America Opioids Sales Quantity Share by Country (2018-2034)
Figure 90. Middle East, Africa and Latin America Opioids Revenue Share by Country (2018-2034)
Figure 91. Brazil Opioids Revenue (2018-2034) & (US$ Million)
Figure 92. Mexico Opioids Revenue (2018-2034) & (US$ Million)
Figure 93. Turkey Opioids Revenue (2018-2034) & (US$ Million)
Figure 94. Israel Opioids Revenue (2018-2034) & (US$ Million)
Figure 95. GCC Countries Opioids Revenue (2018-2034) & (US$ Million)
Figure 96. Opioids Value Chain
Figure 97. Opioids Production Process
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Distributors Profiles
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed